David Mazzo Insider Profile

4 Followers
David Mazzo, President & CEO, Director at Lisata Therapeutics, holds 211.83K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Palisade Bio (Ticker: PALI), holds 200.08K shares in EyePoint Pharmaceuticals (Ticker: EYPT).
tipranks
David Mazzo

David Mazzo
Lisata Therapeutics (LSTA)
President & CEO, Director

Not Ranked
David Mazzo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
79.06%
20.94%
0.00%
A breakdown of David Mazzo's holdings

Insider Roles

EyePoint Pharmaceuticals
(EYPT)
Director
Lisata Therapeutics
(LSTA)
President & CEO, Director
Palisade Bio
(PALI)
Director
Roles that David Mazzo holds in companies

Most Profitable Insider Trade

Stock:
Lisata Therapeutics
(LSTA)
Rating:Informative Buy
Date:Aug 18, 2015 - Aug 18, 2016
Return:-60.90%
The most profitable trade made by David Mazzo

David Mazzo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lisata Therapeutics
Oct 02, 2024
President & CEO, Director
Uninformative Buy
169.94K
$616.44K
Palisade Bio
Director
EyePoint Pharmaceuticals
Oct 11, 2019
Director
Uninformative Buy
65.00K
$2.33M
TBRA
Tobira Therapeutics
$0.00
AVNR
Avanir Pharmaceuticals
Feb 14, 2014
Uninformative Buy
List of latest transactions for each holding click on a transaction to see David Mazzo's performance on stock

David Mazzo insider profile FAQ

What is the percentage of profitable transactions made by David Mazzo?
The percentage of profitable transactions made by David Mazzo is ―.
    What is the average return per transaction made by David Mazzo?
    The average return per transaction made by David Mazzo is ―.
      What stocks does David Mazzo hold?
      David Mazzo holds: LSTA, PALI, EYPT, TBRA, AVNR stocks.
        What was David Mazzo’s latest transaction?
        David Mazzo latest transaction was an Uninformative Buy of $169.94K.
          What was David Mazzo's most profitable transaction?
          David Mazzo’s most profitable transaction was an Informative Buy of LSTA stock on August 18, 2015. The return on the trade was -60.90%.
            What is David Mazzo's role in Lisata Therapeutics?
            David Mazzo's role in Lisata Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.